Cytokinetics, Incorporated Cytokinetics, Incorporated

Cytokinetics, Incorporated

CYTK

Kedudukan dalam Saham #2306
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on... Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Harga Saham
$64.24
Modal Pasaran
$8.93B
Perubahan (1 hari)
2.54%
Perubahan (1 tahun)
8.24%
Negara
US
Perdagangan Cytokinetics, Incorporated (CYTK)

Kategori

Healthcare
Sejarah pecahan saham untuk Cytokinetics, Incorporated (CYTK)
Saham Cytokinetics, Incorporated (simbol: CYTK) telah mengalami sejumlah 1 pecahan saham.
Pecahan saham terkini berlaku pada Jun 25, 2013.
Satu saham CYTK yang dibeli sebelum Jun 25, 2013 kini bersamaan dengan 0.16666666666667 saham CYTK.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
2013-06-25 1:6 x0.16666666666667 x0.16666666666667
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL